Publication Cover
Redox Report
Communications in Free Radical Research
Volume 22, 2017 - Issue 6
2,342
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Pterostilbene protects against UVB-induced photo-damage through a phosphatidylinositol-3-kinase-dependent Nrf2/ARE pathway in human keratinocytes

, , , , , , , , & show all

Figures & data

Table 1. Quantitative RT-PCR primer sequences.

Figure 1. Nrf2 silencing abolished the protective effect of Pter. (A) Viability of HaCaT cells incubated for 24 h in different Pter concentrations. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001. (B) Pter-induced Nrf2 nuclear accumulation. HaCaT cell treatment with Pter for 24 h. The indicated proteins were detected by western blotting. GAPDH and lamin A were used to confirm the purity of the cytosolic and nuclear extracts, respectively. (C) Relative protein level of Nrf2. Quantitative densitometric data were expressed as fold change, the vehicle was set to 1. Values are mean ± SD (n = 3); *P < 0.05, ***P < 0.001. (D) Nrf2 was silenced by transfecting with siRNA. HaCaT cells were transfected with a specific siRNA against Nrf2 (siNrf2) or a non-silencing control (NC-siRNA). The knocking down efficiency was demonstrated by western blotting using GAPDH as a loading control. (E) Quantification densitometric data from (D). Values are mean ± SD (n = 3); ns = P > 0.05, ***P < 0.001, compared with non-transfection control. (F) Cell viability in HaCaT cells treated as indicated. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001.

Figure 1. Nrf2 silencing abolished the protective effect of Pter. (A) Viability of HaCaT cells incubated for 24 h in different Pter concentrations. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001. (B) Pter-induced Nrf2 nuclear accumulation. HaCaT cell treatment with Pter for 24 h. The indicated proteins were detected by western blotting. GAPDH and lamin A were used to confirm the purity of the cytosolic and nuclear extracts, respectively. (C) Relative protein level of Nrf2. Quantitative densitometric data were expressed as fold change, the vehicle was set to 1. Values are mean ± SD (n = 3); *P < 0.05, ***P < 0.001. (D) Nrf2 was silenced by transfecting with siRNA. HaCaT cells were transfected with a specific siRNA against Nrf2 (siNrf2) or a non-silencing control (NC-siRNA). The knocking down efficiency was demonstrated by western blotting using GAPDH as a loading control. (E) Quantification densitometric data from (D). Values are mean ± SD (n = 3); ns = P > 0.05, ***P < 0.001, compared with non-transfection control. (F) Cell viability in HaCaT cells treated as indicated. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001.

Figure 2. Pter activated Nrf2/ARE via PI3K. After transfection with luciferase reporter plasmid for 24 h, HaCaT cells were pretreated for 1 h with LY294002 prior to Pter treatment. (A) Luciferase activity data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001. (B) The indicated proteins were detected by western blotting, with laminA as the loading control. (C) The levels of phosphorylated Nrf2 were quantified by densitometric scanning. Values are mean ± SD (n = 3); **P < 0.01, ***P < 0.001. (D) Cell viability in HaCaT cells treated as indicated. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, *P < 0.05, ***P < 0.001.

Figure 2. Pter activated Nrf2/ARE via PI3K. After transfection with luciferase reporter plasmid for 24 h, HaCaT cells were pretreated for 1 h with LY294002 prior to Pter treatment. (A) Luciferase activity data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, ***P < 0.001. (B) The indicated proteins were detected by western blotting, with laminA as the loading control. (C) The levels of phosphorylated Nrf2 were quantified by densitometric scanning. Values are mean ± SD (n = 3); **P < 0.01, ***P < 0.001. (D) Cell viability in HaCaT cells treated as indicated. Data are presented as percentage of the untreated control ± SD (n = 6); ns = P > 0.05, *P < 0.05, ***P < 0.001.

Figure 3. Pter scavenged UVB-induced ROS via PI3K. HaCaT cells were treated with vehicle, Pter, and LY294002 prior to UVB irradiation. (A) Representative intracellular ROS images and recordings. (B) Quantitative fluorescence data from (A) were presented as mean ± SD (n = 3); ***P < 0.001. (C) Quantitative RT-PCR data of indicated Nrf2 target genes. The relative mRNA levels of Nrf2 target genes were represented as fold change; the vehicle was set to 1 with gapdh and actin for normalization. Values are mean ± SD (n = 3), *P < 0.05.

Figure 3. Pter scavenged UVB-induced ROS via PI3K. HaCaT cells were treated with vehicle, Pter, and LY294002 prior to UVB irradiation. (A) Representative intracellular ROS images and recordings. (B) Quantitative fluorescence data from (A) were presented as mean ± SD (n = 3); ***P < 0.001. (C) Quantitative RT-PCR data of indicated Nrf2 target genes. The relative mRNA levels of Nrf2 target genes were represented as fold change; the vehicle was set to 1 with gapdh and actin for normalization. Values are mean ± SD (n = 3), *P < 0.05.

Figure 4. Pter decreased UV-induced DNA damage via PI3K. (A) Representative tail DNA images, 100× magnification. (B) The percentage of tail DNA from (A) expressed as means ± SD (100 cells were randomly analyzed per sample); ns = P > 0.05, ***P < 0.001.

Figure 4. Pter decreased UV-induced DNA damage via PI3K. (A) Representative tail DNA images, 100× magnification. (B) The percentage of tail DNA from (A) expressed as means ± SD (100 cells were randomly analyzed per sample); ns = P > 0.05, ***P < 0.001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.